Security Features Not Limited to Paper


By Neil Versel

July 29, 2008 | Digital HealthCare & Productivity | Electronic prescribers who want to print prescriptions for Medicaid patients no longer will have to spend up to 10 times the cost of plain paper to comply with new tamper-resistance regulations, the result of intense negotiations between government officials, medical societies, the pharmacy industry, paper manufacturers, and two health-IT advocacy groups.

The Centers for Medicare and Medicaid Services (CMS) last week updated its guidance for rules that take full effect Oct. 1. Starting on that date, paper fee-for-service Medicaid prescriptions must have security features to prevent unauthorized copying, modification, and counterfeiting of prescription forms. But prescribers printing from electronic health records (EHR) or ePrescribing software may generate security features from laser or inkjet printers instead of buying pricey tamper-resistant paper.

“This defines tamper resistance by functionality, not paper,” says Peter Basch, M.D., medical director for ambulatory clinical systems at MedStar Health (Columbia, Md.) Basch, as co-chair of the Physicians’ Electronic Health Records Coalition (PEHRC) pushed for the change during a June 26 forum convened by the National Council for Prescription Drug Programs (NCPDP), a standards-development organization for pharmacy services.

According to Basch, PEHRC and the HIMSS Electronic Health Records Vendors Association convinced CMS and the NCPDP that the technology exists to produce microprinting and “void” pantographs on plain paper with off-the shelf printers. A small Canadian company called AdlerTech International has a patent for pantographs on laser and inkjet printers, and some Hewlett-Packard models can print fonts as small as 0.5 points—just six pixels high.

“Inkjet ink will smear, so that’s a safety feature, too,” Basch adds. Additionally, Basch notes, EHR and ePrescribing software can generate unique numbers for each prescription, in theory making computer-generated prescriptions more difficult to counterfeit than security paper with embossed serial numbers.

The NCPDP details the changes in a letter to state Medicaid directors. Although the correspondence is dated July 18, copies did not go out until CMS revised its guidance last week.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Translational Research Briefing ON Report
Sponsored by GenoLogics

The varied collection of Bio-IT World articles and insights assembled in this Briefing ON examines:

  • The impact of integrating clinical data back into the research and development pipeline.
  • Using information gathered from physical samples, databases, and clinical trials to benefit the design and performance of future research.


Reducing bottlenecks in GMP Laboratories
Sponsored by Waters
Significant time is spent conducting quality control (QC) testing and documenting QC results during the pharmaceutical manufacturing process. GMP regulations require maintaining documentation to ensure strict compliance with established SOP’s. Completing paper documents and ensuring their authenticity creates a bottleneck in the QC laboratory. Waters® NuGenesis® SDMS Intelligent Procedure Manager, an electronic SOP workflow & documentation system, addresses the predominately manual activities required to perform an analytical method. Cycle times are reduced up to 50-75% as compared to a traditional paper trail thereby boosting productivity and accuracy.


Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Medidata Solutions

“What Will Drive Tomorrow’s Health Business Innovation: Technology, Standards or New Business Models?”

This podcast will discuss the current state of health business innovation, particularly around providing solutions for clinical trials and drug development. Executives from Medidata and SAS will address the following questions:

  • Does the health industry need more technology to drive business innovation?
  • How does the current state of industry standards impact the ability of technology to drive business innovation?
  • Is the lack of integration, inability to enter clean data or data privacy issues posing barriers to fully exploiting today’s technology?
  • Are standards and technology adoption hindered by misaligned business models?

Speakers: Glen de Vries, President of Medidata Solutions, and Jason Burke, Global Director of Health and Life Sciences Market Segments, SAS.

Download Now



More Podcasts

Job Openings


Biotechnology Information Management team
Seeks an individual to strategically lead and drive solutions for data management needs stemming from external scientific collaborations. MS in Biology, Bioinformatics, Computer Science, etc. required. Applications must be submitted at www.monsanto.com for consideration. Select req # mons-00010265. We offer very competitive salaries and an extensive benefits package. Monsanto values diversity and is an equal opportunity employer. M/F/D/V

Support Engineer
Titian leads the industry in the supply of software that empowers customers in the management of their scientific samples. Located in Hopkinton, Massachusetts, this position is responsible for the resolution of customer support issues. Candidates should hold a 4 year degree, have a technical background in software or research informatics, have 4+years of experience supporting data management and software solutions, and be proficient in C#.NET, VB6, PL/SQL, ASP. For additional information on this position and our company, visit our website at www.titian.co.uk. To apply, email resume and salary history to [email protected].

Related Resources & Products

Medical Device Development: A Regulatory Overview (2000)
Meeting GMP & ISO 9001 Expectations for Product Development (1996)
State-by-State Clinical Trial Requirements Reference Guide 2006



For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to [email protected].